MS patients may soon get a quick shot instead of a long IV drip
NCT ID NCT07211633
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 25 times
Summary
This study tests whether a shot under the skin (subcutaneous) of the drug ublituximab works as well as the standard IV infusion for people with relapsing multiple sclerosis. About 360 adults with MS will be randomly assigned to one of the two methods. The main goal is to compare drug levels in the blood and check for side effects, aiming to offer a more convenient treatment option.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSING MULTIPLE SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
TG Therapeutics Investigational Trial Site
Banja Luka, 78000, Bosnia and Herzegovina
-
TG Therapeutics Investigational Trial Site
Bihać, 77000, Bosnia and Herzegovina
-
TG Therapeutics Investigational Trial Site
Mostar, 71000, Bosnia and Herzegovina
-
TG Therapeutics Investigational Trial Site
Saravejo, 71000, Bosnia and Herzegovina
-
TG Therapeutics Investigational Trial Site
Pleven, 5800, Bulgaria
-
TG Therapeutics Investigational Trial Site
Plovdiv, 4000, Bulgaria
-
TG Therapeutics Investigational Trial Site
Sofia, 1000, Bulgaria
-
TG Therapeutics Investigational Trial Site
Veliko Tarnovo, 5000, Bulgaria
-
TG Therapeutics Investigational Trial Site
Varaždin, 42000, Croatia
-
TG Therapeutics Investigational Trial Site
Zagreb, 10000, Croatia
-
TG Therapeutics Investigational Trial Site
Brno, 65691, Czechia
-
TG Therapeutics Investigational Trial Site
Hradec Králové, 50005, Czechia
-
TG Therapeutics Investigational Trial Site
Jihlava, 58601, Czechia
-
TG Therapeutics Investigational Trial Site
Ostrava, 70300, Czechia
-
TG Therapeutics Investigational Trial Site
Pardubice, 53002, Czechia
-
TG Therapeutics Investigational Trial Site
Zlín, 76275, Czechia
-
TG Therapeutics Investigational Trial Site
Tbilisi, 0112, Georgia
-
TG Therapeutics Investigational Trial Site
Tbilisi, 0114, Georgia
-
TG Therapeutics Investigational Trial Site
Tbilisi, 0159, Georgia
-
TG Therapeutics Investigational Trial Site
Tbilisi, 0172, Georgia
-
TG Therapeutics Investigational Trial Site
Tbilisi, 0178, Georgia
-
TG Therapeutics Investigational Trial Site
Tbilisi, 0179, Georgia
-
TG Therapeutics Investigational Trial Site
Tbilisi, 0180, Georgia
-
TG Therapeutics Investigational Trial Site
Tbilisi, 3700, Georgia
-
TG Therapeutics Investigational Trial Site
Budapest, H-1033, Hungary
-
TG Therapeutics Investigational Trial Site
Budapest, H-1145, Hungary
-
TG Therapeutics Investigational Trial Site
Kaposvár, H-7400, Hungary
-
TG Therapeutics Investigational Trial Site
Kistarsca, H-2143, Hungary
-
TG Therapeutics Investigational Trial Site
Pécs, H-7623, Hungary
-
TG Therapeutics Investigational Trial Site
Shtip, 7240, North Macedonia
-
TG Therapeutics Investigational Trial Site
Skopje, 1000, North Macedonia
-
TG Therapeutics Investigational Trial Site
Cherkasy, 14029, Ukraine
-
TG Therapeutics Investigational Trial Site
Ivano-Frankivsk, 76000, Ukraine
-
TG Therapeutics Investigational Trial Site
Ivano-Frankivsk, 76018, Ukraine
-
TG Therapeutics Investigational Trial Site
Ivano-Frankivsk, 76493, Ukraine
-
TG Therapeutics Investigational Trial Site
Kyiv, 03037, Ukraine
-
TG Therapeutics Investigational Trial Site
Kyiv, 03115, Ukraine
-
TG Therapeutics Investigational Trial Site
Lviv, 79000, Ukraine
-
TG Therapeutics Investigational Trial Site
Lviv, 79010, Ukraine
-
TG Therapeutics Investigational Trial Site
Ternopil, 46027, Ukraine
-
TG Therapeutics Investigational Trial Site
Vinnytsia, 21002, Ukraine
-
TG Therapeutics Investigational Trial Site
Vinnytsia, 21009, Ukraine
Conditions
Explore the condition pages connected to this study.